December 9, 2016
Valneva to test its Lyme disease vaccine
Valneva said on Friday it will sent its Lyme disease vaccine candidate VLA15 to clinic. Phase I testing can begin…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Thomas Lingelbach
November 2, 2016
GE Healthcare, Valneva join forces to create cell culture medium for vaccine
GE Healthcare and Valneva have joined forces to create cell culture medium for vaccine
December 1, 2015
Velneva’s Clostridium difficile vaccine Candidate meets Phase II trial target
Velneva’s Clostridium difficile vaccine Candidate meets Phase II trial target